Symic Biomedical, a clinical-stage biotherapeutics company developing multiple compounds that target and affect the extracellular matrix (ECM), today announced the selection of SB-061 as the company's [...]
Amarantus Bioscience Holdings, Inc., a biotechnology company, has submitted a request to the US FDA for orphan drug designation (ODD) for eltoprazine in the treatment of levodopa-induced dyskinesia ( [...]
AOBiome today announced it has begun a Phase 2 clinical trial with a therapeutic product candidate based on its proprietary ammonia oxidizing bacteria (AOB) for the treatment of mild to moderate acne [...]
Golden Helix Inc., a leading bioinformatics solutions provider, has now announced the integration of MedGenome's OncoMD into their VarSeq software. The integration will provide VarSeq users with the [...]
AOBiome today announced three appointments to its senior management team to advance the company’s business to develop first-in-class skin health products based on Ammonia Oxidizing Bacteria (AOB). Jo [...]
4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license agreement with Roche to discover and de [...]
During her internship at biotech startup Alector, Helen Lam learned for the first time the advantages that scientists gain by working in a team. She also got a career boost. Helen now works full-time [...]
Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recognizes Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership. N [...]
Symic Biomedical announced today the appointment of Barbara Yanni and William J. Newell to its board of directors. Mr. Newell is the CEO of Sutro Biopharma, Inc. which has entered into a strategic col [...]
Amarantus announced that its abstract titled "The LymPro® Assay: A Biomarker For Alzheimer's Disease Using Blood Samples From Clinically Diagnosed Alzheimer's Disease And Cognitively Intact Subjects" [...]